Helena Jernström
101 – 110 of 123
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2003
-
Mark
Follow-up of patients with Hodgkin's disease following curative treatment: the routine CT scan is of little value
(
- Contribution to journal › Article
-
Mark
A prospective study of different types of hormone replacement therapy use and the risk of subsequent breast cancer: the women's health in the Lund area (WHILA) study (Sweden)
(
- Contribution to journal › Article
-
Mark
Predictors of the plasma ratio of 2-hydroxyestrone to 16alpha-hydroxyestrone among pre-menopausal, nulliparous women from four ethnic groups.
(
- Contribution to journal › Article
- 2002
-
Mark
Familial and hormonal risk factors for papillary serous uterine cancer
(
- Contribution to journal › Article
-
Mark
Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
(
- Contribution to journal › Article
- 2001
-
Mark
CYP gene polymorphisms and early menarche
(
- Contribution to journal › Article
-
Mark
Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: implications for premenopausal breast cancer risk
(
- Contribution to journal › Article
-
Mark
Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women
(
- Contribution to journal › Article
-
Mark
Re: CYP17 promoter polymorphism and breast cancer in Australian women under age forty years
(
- Contribution to journal › Letter
- 1999
-
Mark
Hormone replacement therapy before breast cancer diagnosis significantly reduces the overall death rate compared with never-use among 984 breast cancer patients
(
- Contribution to journal › Article